Navigation Links
As FDA Eyes Prostate Cancer Drugs, Experts Urge Caution
Date:5/4/2010

here are studies that have shown that men with advanced prostate cancer who take hormone therapy face a twofold increased risk of developing metabolic syndrome, a cluster of symptoms tied to the development of heart disease.

"When I speak to patients who have to go on these agents, I counsel them about the risks of increased weight gain and I tell them they need to monitor their carbohydrate intake and increase their amount of exercise, and they can decrease the risk of developing metabolic syndrome," he said.

Patients with prostate cancer typically do have some treatment choices. After initial treatment for prostate cancer, whether by surgery or radiation, doctors usually track blood levels of disease-linked prostate-specific antigen (PSA) over time. Based on that, one can initiate hormone therapy, Soloway said, or simply wait and monitor the patient.

"There is further evidence that you should not begin hormone treatment until such time when there is more compelling reason than just a slight rise in PSA," Soloway said. "There are hundreds and hundreds of thousands of such patients."

Soloway believes that many men across the United States are unnecessarily taking hormone therapy for prostate tumors that have not yet spread. "I think hormone therapy can be delayed for months to years in some of these men," he said.

For men with more advanced metastatic prostate cancer, hormone therapy can be used for several months until the PSA goes down, at which point the therapy can be stopped, Soloway said. "If you stop it for the time it takes for the PSA to rise again, that could be many months to a couple or more years," he said.

Men taking hormone therapy need to understand that, as with any drug treatment, there are some risks, Soloway said. But heart disease is largely preventable, and he believes that GnRH agonists might boost heart risks because they cause men to pile on extra pounds.

So, "you want
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Prostate Cancer Diagnosis Raises Suicide Risk
2. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis
3. Loss of gene function makes prostate cancer cells more aggressive
4. Experts Issue Warning on Prostate Hormone Therapy
5. Biochemical profile may help diagnose, determine aggressiveness of prostate cancer
6. New Scan May Help Find Aggressive Prostate Tumors
7. Vaccine approach extends life of metastatic prostate cancer patients
8. Prostate Cancer Care Varies By Hospital Type
9. Study confirms prostate cancer is treated differently at county vs. private hospitals
10. Beer Ingredient Eyed in Prostate Cancer Prevention
11. Race, Weight May Influence Success of Prostate Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Ca (PRWEB) May 29, 2015 ... pain consultations with specialists, physical therapy, and injections ... experiencing mid back and/or lower back pain, Healthpointe ... epidural injections for herniated discs, disc protrusions and ... . , Healthpointe’s team of renowned surgeons ...
(Date:5/29/2015)... 2015 The Global Allopurinol Industry ... on the current state of the Allopurinol industry.With ... statistics on the state of the industry and ... for companies and individuals interested in the market. ... industry including definitions, classifications, applications and industry chain ...
(Date:5/29/2015)... May 29, 2015 Designed with the ... up to create an all new, exclusive line of ... formulated with the latest and greatest, high impact, result ... to be effective. The 24/7 Series can be used ... and even the casual fitness enthusiasts. There are no ...
(Date:5/29/2015)... 29, 2015 Javlin continues to fulfill ... headquarters and a larger team, with the intention to ... market share in the U.S. and Canada. , Javlin ... achieved significant growth in 2014 with its strongest earnings ... data integration platform, CloverETL. To accelerate further progress and ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 This ... current state of the Naproxen industry.The report provides ... classifications, applications and industry chain structure. The ... international markets including development trends, competitive landscape analysis, ... are discussed as well as manufacturing processes and ...
Breaking Medicine News(10 mins):Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Allopurinol Industry (Global, China) 2015 Research Analysis and 2020 Forecasts 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Growth of Data Integration Platform CloverETL Continues in North America 2Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2
... Group Upgrades from Allscripts Document Management; Expects ... Break-Even on Clinical & Financial Investment, CHICAGO ... leading provider of clinical software, connectivity and,information solutions ... The Heart Center Medical Group has selected the ...
... Medicare Fraud Strike Force, WASHINGTON, April 30 ... late yesterday of Medicare fraud,Assistant Attorney General Alice S. ... Acosta of the Southern District of Florida,announced today., ... Caos, 62, guilty on all,charged counts, including: conspiracy to ...
... PARK, Ohio, April 30 "Opportunities for,Next-Generation ... Medical,Devices Conference, will bring together the diverse ... cardiovascular, orthopaedic,neurological and pulmonary applications., Hosted ... world,s leading,materials society, this unique forum will ...
... Idiopathic pulmonary fibrosis (IPF) patients learn from specialists,seek ... The following announcement,was released by The Coalition ... Free Educational Seminar for Patients and Their,Families, ... with The,Coalition for Pulmonary Fibrosis (CPF), is hosting ...
... Pa., April 30 West Pharmaceutical,Services, Inc., (NYSE: ... 2008,Annual Meeting of Shareholders. The meeting will be held ... The live webcast can be accessed through the ... Please allow extra time prior,to the live webcast to ...
... for all holders of a valid press card / formal ... press facilities, including a working room, and the press office ... relevant experts. , You can register for ... direct any queries to the EULAR Press Office on ...
Cached Medicine News:Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 2Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 3Health News:The Heart Center Selects Allscripts Electronic Health Record and Practice Management for 50 Physicians 4Health News:Miami Jury Convicts Dermatologist of Medicare Fraud 2Health News:Medical Device Innovators to Discuss Next Generation of Implants at Cleveland Conference 2Health News:Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center 2Health News:Pulmonary Fibrosis Patients Meet With Top Lung Doctors at Beth Israel Deaconess Medical Center 3Health News:West Pharmaceutical Services, Inc. Announces Annual Meeting Webcast 2
(Date:5/28/2015)... -- Eli Lilly and Company (NYSE: LLY ) announced today ... for up to $1.6 billion aggregate principal amount of certain ... who tendered, and did not validly withdraw, their notes on ... time, on May 27, 2015 (the early tender date), ... to receive the total consideration. The total consideration for each ...
(Date:5/28/2015)... DUBLIN , May 28, 2015 /PRNewswire/ ... ) has announced the addition of Jain ... and Companies"  to their offering.  ... interference (RNAi) or gene silencing involves the ... inside the cell, this material is processed ...
(Date:5/28/2015)... May 28, 2015 AlloSource ®, ... cellular, bone, skin and soft-tissue allografts for use ... patient healing, today announced that AlloWrap® DS, its ... to the high-cost reimbursement category. ... and their patients," said Kimberly French , ...
Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3AlloSource Announces Milestone In Reimbursement For AlloWrap DS 2
... WEBSTER, Texas, Nov. 10, 2011 IDEV Technologies, Incorporated ... for the company,s 6 French (6Fr) SUPERA VERITAS Transhepatic ... for sale outside the U.S. earlier this year, is ... the unique SUPERA stent, currently cleared in the U.S. ...
... Vascular Designs, Inc., a medical device manufacturing company, today ... FDA marketing clearance in 2009 – is now in ... in the treatment of liver cancer. The IsoFlow™ Infusion ... target and isolate areas within the body where the ...
Cached Medicine Technology:IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System 2Breakthrough Cancer Treatment Now in Use at UC Davis Medical Center 2
Medium....
Goldman single hook....
These products are supplied non-sterile and must be sterilized before use. For insertion through the smokevac and nezhat-dorsey trumpet valve in conjunction with the universal instrument insert adapt...
The Accuref 8001 allows you to measure much smaller pupils than conventional units and 3 step Target light adjuster ensures accurate results....
Medicine Products: